Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study
Aim. To study the epidemiological characteristics and changes of hypertension (HTN), as well as factors associated with HTN in the Russian population aged 35-74 years.Material and methods. The Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation-3 (ESSE-RF3...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2023-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3785 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849250122226991104 |
|---|---|
| author | Yu. A. Balanova O. M. Drapkina V. A. Kutsenko A. E. Imaeva A. V. Kontsevaya S. A. Maksimov G. A. Muromtseva M. B. Kotova N. S. Karamnova S. E. Evstifeeva A. V. Kapustina O. A. Litinskaya M. S. Pokrovskaya E. M. Filichkina O. E. Ivlev L. I. Gomanova Yu. V. Doludin I. A. Efimova A. L. Borisova B. M. Nazarov E. B. Yarovaya T. V. Repkina T. O. Gonoshilova A. V. Kudryavtsev N. I. Belova L. L. Shagrov M. A. Samotrueva A. L. Yasenyavskaya E. N. Chernysheva S. V. Glukhovskaya I. A. Levina E. A. Shirshova E. B. Dorzhieva E. Z. Urbanova N. Yu. Borovkova V. K. Kurashin A. S. Tokareva Yu. I. Ragino G. I. Simonova A. D. Khudyakova V. N. Nikulin O. R. Aslyamov G. V. Khokhlova A. V. Solovyova A. A. Rodionov O. V. Kryachkova Yu. Yu. Shamurova I. V. Tantsyreva I. N. Baryshnikova M. G. Ataev M. O. Radjabov M. M. Isakhanova M. A. Umetov L. V. Elgarova I. A. Khakuasheva E. I. Yamashkina M. V. Esina T. A. Kunyaeva A. M. Nikitina N. V. Savvina Yu. E. Spiridonova E. A. Naumova A. A. Keskinov D. A. Kashtanova V. S. Yudin S. M. Yudin S. A. Shalnova |
| author_facet | Yu. A. Balanova O. M. Drapkina V. A. Kutsenko A. E. Imaeva A. V. Kontsevaya S. A. Maksimov G. A. Muromtseva M. B. Kotova N. S. Karamnova S. E. Evstifeeva A. V. Kapustina O. A. Litinskaya M. S. Pokrovskaya E. M. Filichkina O. E. Ivlev L. I. Gomanova Yu. V. Doludin I. A. Efimova A. L. Borisova B. M. Nazarov E. B. Yarovaya T. V. Repkina T. O. Gonoshilova A. V. Kudryavtsev N. I. Belova L. L. Shagrov M. A. Samotrueva A. L. Yasenyavskaya E. N. Chernysheva S. V. Glukhovskaya I. A. Levina E. A. Shirshova E. B. Dorzhieva E. Z. Urbanova N. Yu. Borovkova V. K. Kurashin A. S. Tokareva Yu. I. Ragino G. I. Simonova A. D. Khudyakova V. N. Nikulin O. R. Aslyamov G. V. Khokhlova A. V. Solovyova A. A. Rodionov O. V. Kryachkova Yu. Yu. Shamurova I. V. Tantsyreva I. N. Baryshnikova M. G. Ataev M. O. Radjabov M. M. Isakhanova M. A. Umetov L. V. Elgarova I. A. Khakuasheva E. I. Yamashkina M. V. Esina T. A. Kunyaeva A. M. Nikitina N. V. Savvina Yu. E. Spiridonova E. A. Naumova A. A. Keskinov D. A. Kashtanova V. S. Yudin S. M. Yudin S. A. Shalnova |
| author_sort | Yu. A. Balanova |
| collection | DOAJ |
| description | Aim. To study the epidemiological characteristics and changes of hypertension (HTN), as well as factors associated with HTN in the Russian population aged 35-74 years.Material and methods. The Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation-3 (ESSE-RF3) study examined a representative sample of the population aged 35-74 years of 15 Russian regions with a response >70% (n=28611). Modular design questionnaire was used. Blood pressure (BP) was measured twice after a 5-minute rest in a sitting position on the right arm with an Omron blood pressure monitor. There were following criteria for hypertension: systolic blood pressure (SBP) ≥140 mm Hg and/or diastolic blood pressure (DBP) ≥90 mm Hg, and/or antihypertensive therapy. The effectiveness of treatment was considered the proportion (%) of people who achieved target blood pressure values among those being treated, while the control was considered the proportion (%) of patients with a BP <140/90 mm Hg of the total number of hypertensive patients. HTN changes were studied in a single age range of 35-64 years with the inclusion of materials from the ESSE-RF (2012-14) and ESSE-RF2 (2017) studies, carried out using the same methodology as ESSE-RF3. Statistical analysis was carried out using the open-source R 3.6.1 environment. Analysis of the association between factors and a binary variable was performed using logistic regression. The significance level for all tested hypotheses was 0,05.Results. According to ESSE-RF3, the average levels of SBP and DBP in the population were 131,9±18,7 and 84,4±10,9 mm Hg, respectively, while the proportion of those with BP ≥140/90 mm Hg — 38,8% (men: 44,8%, women: 33,9%). Prevalence of hypertension was 53,9% (men: 56,0%, women: 52,1%), awareness — 77,7% (men: 71,5%, women: 82,3%), while the treatment received 63,4%, significantly higher among women than among men: 72,3 vs 53,3%. The effectiveness of treatment was 44,0%, higher among women compared to men (48,2 vs 37,4%). In addition, 27,9% of patients have controlled HTN.Conclusion. The problem of controlled HTN in Russia remains unresolved in the 21st century. The following significant sex differences remain: the prevalence of HTN is higher among men, but awareness of the disease, treatment rate and its effectiveness are lower compared to women. |
| format | Article |
| id | doaj-art-f4f3bb1a0fc14acbbb3642f106f9ee6a |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2023-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-f4f3bb1a0fc14acbbb3642f106f9ee6a2025-08-20T03:57:21Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252023-12-01228S10.15829/1728-8800-2023-37852825Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 studyYu. A. Balanova0O. M. Drapkina1V. A. Kutsenko2A. E. Imaeva3A. V. Kontsevaya4S. A. Maksimov5G. A. Muromtseva6M. B. Kotova7N. S. Karamnova8S. E. Evstifeeva9A. V. Kapustina10O. A. Litinskaya11M. S. Pokrovskaya12E. M. Filichkina13O. E. Ivlev14L. I. Gomanova15Yu. V. Doludin16I. A. Efimova17A. L. Borisova18B. M. Nazarov19E. B. Yarovaya20T. V. Repkina21T. O. Gonoshilova22A. V. Kudryavtsev23N. I. Belova24L. L. Shagrov25M. A. Samotrueva26A. L. Yasenyavskaya27E. N. Chernysheva28S. V. Glukhovskaya29I. A. Levina30E. A. Shirshova31E. B. Dorzhieva32E. Z. Urbanova33N. Yu. Borovkova34V. K. Kurashin35A. S. Tokareva36Yu. I. Ragino37G. I. Simonova38A. D. Khudyakova39V. N. Nikulin40O. R. Aslyamov41G. V. Khokhlova42A. V. Solovyova43A. A. Rodionov44O. V. Kryachkova45Yu. Yu. Shamurova46I. V. Tantsyreva47I. N. Baryshnikova48M. G. Ataev49M. O. Radjabov50M. M. Isakhanova51M. A. Umetov52L. V. Elgarova53I. A. Khakuasheva54E. I. Yamashkina55M. V. Esina56T. A. Kunyaeva57A. M. Nikitina58N. V. Savvina59Yu. E. Spiridonova60E. A. Naumova61A. A. Keskinov62D. A. Kashtanova63V. S. Yudin64S. M. Yudin65S. A. Shalnova66National Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State UniversityNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State UniversityNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineCity Polyclinic № 109National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State UniversityRegional Center for Public Health and Medical PreventionRegional Center for Public Health and Medical PreventionNorthern State Medical UniversityNorthern State Medical UniversityNorthern State Medical UniversityAstrakhan State Medical UniversityAstrakhan State Medical UniversityAstrakhan State Medical UniversitySverdlovsk Regional Medical CollegeSverdlovsk Regional Medical CollegeSverdlovsk Regional Medical CollegeBoyanov Center for Public Health and Medical PreventionBoyanov Center for Public Health and Medical PreventionPrivolzhsky Research Medical UniversityPrivolzhsky Research Medical UniversityPrivolzhsky Research Medical UniversityResearch Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and GeneticsResearch Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and GeneticsResearch Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and GeneticsOrenburg Regional Center for Public Health and Medical PreventionOrenburg Regional Center for Public Health and Medical PreventionOrenburg Regional Center for Public Health and Medical PreventionTver State Medical UniversityTver State Medical UniversityTver State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversityAbusuev Research Institute of Environmental Medicine, Dagestan State Medical UniversityAbusuev Research Institute of Environmental Medicine, Dagestan State Medical UniversityAbusuev Research Institute of Environmental Medicine, Dagestan State Medical UniversityBerbekov Kabardino-Balkarian State UniversityBerbekov Kabardino-Balkarian State UniversityBerbekov Kabardino-Balkarian State UniversityOgarev Mordovian State UniversityOgarev Mordovian State UniversityOgarev Mordovian State University; Mordovian Republican Central Clinical HospitalRepublican Center for Public Health and Medical PreventionAmmosov North-Eastern Federal UniversityRepublican Center for Public Health and Medical PreventionRepublican Center for Public Health and Medical Prevention, Exercise therapy and Sports MedicineCenter for Strategic Planning and Management of Biomedical Health RisksCenter for Strategic Planning and Management of Biomedical Health RisksCenter for Strategic Planning and Management of Biomedical Health RisksCenter for Strategic Planning and Management of Biomedical Health RisksNational Medical Research Center for Therapy and Preventive MedicineAim. To study the epidemiological characteristics and changes of hypertension (HTN), as well as factors associated with HTN in the Russian population aged 35-74 years.Material and methods. The Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation-3 (ESSE-RF3) study examined a representative sample of the population aged 35-74 years of 15 Russian regions with a response >70% (n=28611). Modular design questionnaire was used. Blood pressure (BP) was measured twice after a 5-minute rest in a sitting position on the right arm with an Omron blood pressure monitor. There were following criteria for hypertension: systolic blood pressure (SBP) ≥140 mm Hg and/or diastolic blood pressure (DBP) ≥90 mm Hg, and/or antihypertensive therapy. The effectiveness of treatment was considered the proportion (%) of people who achieved target blood pressure values among those being treated, while the control was considered the proportion (%) of patients with a BP <140/90 mm Hg of the total number of hypertensive patients. HTN changes were studied in a single age range of 35-64 years with the inclusion of materials from the ESSE-RF (2012-14) and ESSE-RF2 (2017) studies, carried out using the same methodology as ESSE-RF3. Statistical analysis was carried out using the open-source R 3.6.1 environment. Analysis of the association between factors and a binary variable was performed using logistic regression. The significance level for all tested hypotheses was 0,05.Results. According to ESSE-RF3, the average levels of SBP and DBP in the population were 131,9±18,7 and 84,4±10,9 mm Hg, respectively, while the proportion of those with BP ≥140/90 mm Hg — 38,8% (men: 44,8%, women: 33,9%). Prevalence of hypertension was 53,9% (men: 56,0%, women: 52,1%), awareness — 77,7% (men: 71,5%, women: 82,3%), while the treatment received 63,4%, significantly higher among women than among men: 72,3 vs 53,3%. The effectiveness of treatment was 44,0%, higher among women compared to men (48,2 vs 37,4%). In addition, 27,9% of patients have controlled HTN.Conclusion. The problem of controlled HTN in Russia remains unresolved in the 21st century. The following significant sex differences remain: the prevalence of HTN is higher among men, but awareness of the disease, treatment rate and its effectiveness are lower compared to women.https://cardiovascular.elpub.ru/jour/article/view/3785hypertension prevalencetreatment rateeffectiveness of hypertension treatmentsystolic blood pressurediastolic blood pressurehypertension control |
| spellingShingle | Yu. A. Balanova O. M. Drapkina V. A. Kutsenko A. E. Imaeva A. V. Kontsevaya S. A. Maksimov G. A. Muromtseva M. B. Kotova N. S. Karamnova S. E. Evstifeeva A. V. Kapustina O. A. Litinskaya M. S. Pokrovskaya E. M. Filichkina O. E. Ivlev L. I. Gomanova Yu. V. Doludin I. A. Efimova A. L. Borisova B. M. Nazarov E. B. Yarovaya T. V. Repkina T. O. Gonoshilova A. V. Kudryavtsev N. I. Belova L. L. Shagrov M. A. Samotrueva A. L. Yasenyavskaya E. N. Chernysheva S. V. Glukhovskaya I. A. Levina E. A. Shirshova E. B. Dorzhieva E. Z. Urbanova N. Yu. Borovkova V. K. Kurashin A. S. Tokareva Yu. I. Ragino G. I. Simonova A. D. Khudyakova V. N. Nikulin O. R. Aslyamov G. V. Khokhlova A. V. Solovyova A. A. Rodionov O. V. Kryachkova Yu. Yu. Shamurova I. V. Tantsyreva I. N. Baryshnikova M. G. Ataev M. O. Radjabov M. M. Isakhanova M. A. Umetov L. V. Elgarova I. A. Khakuasheva E. I. Yamashkina M. V. Esina T. A. Kunyaeva A. M. Nikitina N. V. Savvina Yu. E. Spiridonova E. A. Naumova A. A. Keskinov D. A. Kashtanova V. S. Yudin S. M. Yudin S. A. Shalnova Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study Кардиоваскулярная терапия и профилактика hypertension prevalence treatment rate effectiveness of hypertension treatment systolic blood pressure diastolic blood pressure hypertension control |
| title | Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study |
| title_full | Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study |
| title_fullStr | Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study |
| title_full_unstemmed | Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study |
| title_short | Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study |
| title_sort | hypertension in the russian population during the covid 19 pandemic sex differences in prevalence treatment and its effectiveness data from the esse rf3 study |
| topic | hypertension prevalence treatment rate effectiveness of hypertension treatment systolic blood pressure diastolic blood pressure hypertension control |
| url | https://cardiovascular.elpub.ru/jour/article/view/3785 |
| work_keys_str_mv | AT yuabalanova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT omdrapkina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT vakutsenko hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT aeimaeva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT avkontsevaya hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT samaksimov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT gamuromtseva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT mbkotova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT nskaramnova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT seevstifeeva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT avkapustina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT oalitinskaya hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT mspokrovskaya hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT emfilichkina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT oeivlev hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ligomanova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT yuvdoludin hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT iaefimova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT alborisova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT bmnazarov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ebyarovaya hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT tvrepkina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT togonoshilova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT avkudryavtsev hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT nibelova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT llshagrov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT masamotrueva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT alyasenyavskaya hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT enchernysheva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT svglukhovskaya hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ialevina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT eashirshova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ebdorzhieva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ezurbanova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT nyuborovkova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT vkkurashin hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT astokareva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT yuiragino hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT gisimonova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT adkhudyakova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT vnnikulin hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT oraslyamov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT gvkhokhlova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT avsolovyova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT aarodionov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ovkryachkova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT yuyushamurova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT ivtantsyreva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT inbaryshnikova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT mgataev hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT moradjabov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT mmisakhanova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT maumetov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT lvelgarova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT iakhakuasheva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT eiyamashkina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT mvesina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT takunyaeva hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT amnikitina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT nvsavvina hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT yuespiridonova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT eanaumova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT aakeskinov hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT dakashtanova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT vsyudin hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT smyudin hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study AT sashalnova hypertensionintherussianpopulationduringthecovid19pandemicsexdifferencesinprevalencetreatmentanditseffectivenessdatafromtheesserf3study |